breath-based diagnostics
Owlstone Medical Raises $27M in Series E Round
The UK-based company is developing tests based on a technology that analyzes breath-based biomarkers.
Breath Diagnostics Closes $1M Financing Round to Support Breath-Based Test Platform Development
The firm also appointed Aaron Roebuck as president, saying he will help the company to develop and commercialize its breath-based testing platform.
The firm is nearing the launch of a liver disease test and working with the FDA to develop standards for the detection of naturally occurring compounds.
The Maryland-based firm reported in a recent proof-of-concept study that It used protease biomarkers to identify patients with lower respiratory tract infections.
Top Five Articles on 360Dx Last Week: Roche’s New PCR Technology; Abionic Sepsis POC Test; More
Last week, readers were most interested in a story about a new respiratory test launched by Roche leveraging a new PCR technology.
Mar 26, 2024
Aug 22, 2023
Aug 16, 2022
Imspex Gains CE-IVD Mark for COVID-19 Breath Test
Jun 22, 2022
Gemelli Biotech Raises $19M in Series A Round
Nov 15, 2021
Nov 9, 2021